These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2515007)

  • 1. Treatment of chronic experimental Trypanosoma cruzi infections in mice with MK-436, a 2-substituted 5-nitroimidazole.
    Andrade SG; Silva RC; Santiago CM
    Bull World Health Organ; 1989; 67(5):509-14. PubMed ID: 2515007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.
    Andrade SG; Silva RC; Santiago CM; Freitas LA
    Bull World Health Organ; 1987; 65(5):625-33. PubMed ID: 3123082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
    Andrade SG; Magalhães JB; Pontes AL
    Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes.
    Toledo MJ; Bahia MT; Veloso VM; Carneiro CM; Machado-Coelho GL; Alves CF; Martins HR; Cruz RE; Tafuri WL; Lana M
    J Antimicrob Chemother; 2004 Jun; 53(6):1045-53. PubMed ID: 15102747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure.
    Romanha AJ; Alves RO; Murta SM; Silva JS; Ropert C; Gazzinelli RT
    J Infect Dis; 2002 Sep; 186(6):823-8. PubMed ID: 12198617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy.
    Andrade SG; Stocker-Guerret S; Pimentel AS; Grimaud JA
    Mem Inst Oswaldo Cruz; 1991; 86(2):187-200. PubMed ID: 1842413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and mice.
    Murray PK; Habbersett MC; Meurer RD
    Am J Trop Med Hyg; 1983 Nov; 32(6):1242-50. PubMed ID: 6418014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New process for screening of drugs in experimental infection with Trypanosoma cruzi].
    Campos R; Amato Neto V; de Souza HB; Braz LM
    Rev Inst Med Trop Sao Paulo; 1991; 33(4):325-7. PubMed ID: 1844956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutically acitve nitro compounds. 4. 5-Nitroimidazoles (Part III).
    Winkelmann E; Raether W
    Arzneimittelforschung; 1978; 28(5):739-49. PubMed ID: 107955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox].
    Andrade SG; Magalhães JB; Pontes AL
    Rev Soc Bras Med Trop; 1989; 22(3):113-8. PubMed ID: 2518608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice.
    Malanga CM; Conroy J; Cuckler AC
    J Parasitol; 1981 Feb; 67(1):35-40. PubMed ID: 6785408
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice.
    Andrade SG; Freitas LA; Peyrol S; Pimentel AR; Sadigursky M
    Bull World Health Organ; 1991; 69(2):191-7. PubMed ID: 1907221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous system involvement.
    Jennings FW; Urquhart GM; Murray PK; Miller BM
    Trans R Soc Trop Med Hyg; 1983; 77(5):693-8. PubMed ID: 6659049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice.
    Ferreira ME; Nakayama H; de Arias AR; Schinini A; de Bilbao NV; Serna E; Lagoutte D; Soriano-Agatón F; Poupon E; Hocquemiller R; Fournet A
    J Ethnopharmacol; 2007 Jan; 109(2):258-63. PubMed ID: 16949231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
    Bustamante JM; Presti MS; Rivarola HW; Fernández AR; Enders JE; Fretes RE; Paglini-Oliva P
    Int J Antimicrob Agents; 2007 Jun; 29(6):733-7. PubMed ID: 17395432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains.
    Andrade SG; Rassi A; Magalhaes JB; Ferriolli Filho F; Luquetti AO
    Trans R Soc Trop Med Hyg; 1992; 86(6):624-6. PubMed ID: 1287919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection].
    Moreno EA; Rivera IM; Moreno SC; Alarcón ME; Lugo-Yarbuh A
    Invest Clin; 2003 Sep; 44(3):241-54. PubMed ID: 14552062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fexinidazole: a potential new drug candidate for Chagas disease.
    Bahia MT; de Andrade IM; Martins TA; do Nascimento ÁF; Diniz Lde F; Caldas IS; Talvani A; Trunz BB; Torreele E; Ribeiro I
    PLoS Negl Trop Dis; 2012; 6(11):e1870. PubMed ID: 23133682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.